Autoimmune encephalitis: neurologist’s view (complex questions of diagnostics)
https://doi.org/10.21886/2712-8156-2025-6-1-19-26
Abstract
Autoimmune encephalitides (AIE) are non-infectious immune-mediated inflammatory diseases of the brain parenchyma with frequent lesions of the cortex or deep gray matter with or without involvement of the white matter, meninges, or spinal cord. The most common clinical syndromes of AIE are disorders of the psyche, behavior, cognitive and autonomic functions, movement disorders, as well as epileptic seizures. The diagnosis of AIE can be complicated by the isolated presentation of psychopathological hallucinatory-delusional and emotional-affective symptoms, which can imitate the onset of an idiopathic mental disorder and requires a certain alertness and increased attention to the anamnesis data and assessment of the neurological status. The MRI pattern of limbic encephalitis with unilateral or bilateral involvement of the medial temporal lobes is typical for AIE, however, both normal MRI of the brain and/or spinal cord and involvement of various brain regions in different subtypes of AIE are possible. It is necessary to consider the possibility of not only a recurrent course of AIE, but also the possibility of the overlapping syndromes of AIE and other autoimmune disorders development, including demyelinating diseases – multiple sclerosis, neuromyelitis optica spectrum disorders or diseases associated with antibodies to myelin oligodendrocyte glycoprotein, which requires longer observation due to the risk of relapse of autoimmune diseases.
Keywords
About the Authors
Yu. N. SorokinRussian Federation
Yuri N. Sorokin, Doctor of Medical Sciences, Associate Professor; Professor
Department of Neurology and Regenerative Medicine with a course in Osteopathy
Rostov-on-Don
E. Yu. Sorokina
Russian Federation
Elena Yu. Sorokina, Senior lecturer
Department of Foreign Languages with Latin language course
Rostov-on-Don
References
1. Graus F., Titulaer M.J, Balu R. Benseler S., Bien Ch.G., Cellucci Т. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(04):391-404. DOI: 10.1016/S1474-4422(15)00401-9
2. Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92(7):757-768. DOI: 10.1136/jnnp-2020-325300
3. Polonsky Е.L., Skulyabin D.I., Lapin S.V., Krasakov I.V., Tikhomirova O.V., Nazarov V.D. et al. [Polymorphism of autoimmune encephalitis]. Annals of Clinical and Experimental Neurology. 2019;13(2):79-91. (In Russian). DOI: 10.25692/ACEN.2019.2.9
4. Shan W, Yang H, Wang Q. Neuronal Surface Antibody-Medicated Autoimmune Encephalitis (Limbic Encephalitis) in China: A Multiple-Center, Retrospective Study. Front Immunol. 2021;12:621599. DOI: 10.3389/fimmu.2021.621599
5. Arbizu J, Gállego Pérez-Larraya J, Hilario A, Gómez Grande A, Rubí S, Camacho V; et al. Update on the diagnosis of encephalitis. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022;41(4):247-257. DOI: 10.1016/j.remnie.2022.05.003
6. Yang M, Lian Y. Clinical Features and Early Recognition of 242 Cases of Autoimmune Encephalitis. Front Neurol. 2022;12:803752. DOI: 10.3389/fneur.2021.803752
7. Sorokin Yu.N., Sorokina E.Yu. Peculiarities of epileptic seizures in autoimmune encephalitis. Universitetskaya klinika (University clinic). 2022;(S2):297-299. (In Russ.).
8. Yevtushenko S.K., Sorokin Yu.N. Epileptic manifestations of autoimmune encephalitis. Russian neurological journal. 2023;28(4):81-86. (In Russ.) DOI: 10.30629/2658-7947-2023-28-4-81-86
9. Isaeva N.V., Prokopenko S.V., Rodikov M.V., Abroskina M.V., Ondar V.S., Subocheva S.A., et al. Stiff-person syndrome: a clinical observation. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(6):96‑100. (In Russ.) DOI: 10.17116/jnevro201911906196
10. Khoreva M.A., Serikova I.Y., Smagina I.V., Golenko A.A., Smirnov K.V., Zavyalov A.E., et al. Clinical case of anti-NMDA receptor encephalitis associated with new coronaviral infection (COVID-19). Russian neurological journal. 2022;27(1):106-112. (In Russ.) DOI: 10.30629/2658-7947-2022-27-1-106-112
11. Panchenko N.I., Shuleshova N.V., Rudenko D.I., Skulyabin D.I., Kolchev S.A., Perfilev S.V., et al. Autoimmune аnti-NMDA encephalitis associated with the new coronavirus infection COVID-19. Russian neurological journal. 2023;28(4):60-67. (In Russ.) DOI: 10.30629/2658-7947-2023-28-4-60-67
12. Murashko A.A. Anti-NMDA receptor encephalitis mimic psychiatric disorders. Social and clinical psychiatry (Socialynaya i klinicheskaya psihiatriya). 2022;32(4):59-67. eLIBRARY ID: 50489610 EDN: LJESPJ
13. DeSena AD, Greenberg BM, Graves D. Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis. Pediatr Neurol. 2014;51(4):542-549. DOI: 10.1016/j.pediatrneurol.2014.04.030
14. Hartung TJ, Bartels F, Kuchling J, Krohn S, Leidel J, Mantwill M, et al. MRI findings in autoimmune encephalitis. Rev Neurol (Paris). 2024;180(9):895-907. DOI: 10.1016/j.neurol.2024.08.006
15. Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol. 2019;32(3):452-458. DOI: 10.1097/WCO.0000000000000676
16. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T,et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157-165. DOI: 10.1016/S1474-4422(12)70310-1
17. Zhong R, Chen Q, Zhang X, Zhang H, Lin W. Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study. Front Immunol. 2022;13:918396. DOI: 10.3389/fimmu.2022.918396
18. Yang B, Yu N. Glucocorticoid-dependent multiple sclerosis overlapping anti-NMDA receptor encephalitis : a case report and literature review update. Neurol Sci. 2024;45(1):83-92. DOI: 10.1007/s10072-023-07034-x
19. Wurdack K, Prüss H, Finke C. Evolution from viral encephalitis to autoimmune encephalitis to multiple sclerosis: a case report. J Neurol. 2024;271:7035-7038. DOI: 10.1007/s00415-024-12659-9
20. Tao S, Zhang Y, Ye H, Guo D. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis : A case report and literature review. Mult Scler Relat Disord. 2019;35:185-192. DOI: 10.1016/j.msard.2019.07.008
21. Yin XJ, Zhang LF, Bao LH, Feng ZC, Chen JH, Li BX, et al. Overlapping syndrome of recurrent anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein demyelinating diseases: A case report. World J Clin Cases. 2022;10(18):6148-6155. DOI: 10.12998/wjcc.v10.i18.6148
Review
For citations:
Sorokin Yu.N., Sorokina E.Yu. Autoimmune encephalitis: neurologist’s view (complex questions of diagnostics). South Russian Journal of Therapeutic Practice. 2025;6(1):19-26. (In Russ.) https://doi.org/10.21886/2712-8156-2025-6-1-19-26